These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11411094)

  • 1. High-dose vitamin C therapy for inclusion body myositis.
    Yamada T; Minohara M; Imaiso Y; Sakae N; Hara H; Tanaka K; Yamamoto T; Taniwaki T; Furuya H; Kira J
    Fukuoka Igaku Zasshi; 2001 Apr; 92(4):99-104. PubMed ID: 11411094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial inflammatory inclusion body myositis.
    Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
    Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection].
    Warabi Y; Matsubara S; Mizutani T; Hayashi H
    Rinsho Shinkeigaku; 2004 Sep; 44(9):609-14. PubMed ID: 15515704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic muscle MRI abnormality in a patient with inclusion body myositis].
    Ono K; Takizawa Y; Komai K; Nitta E; Takamori M
    Rinsho Shinkeigaku; 1998 May; 38(5):468-70. PubMed ID: 9805998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term observational study of sporadic inclusion body myositis.
    Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D
    Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variable immunodeficiency (CVID) and inclusion body myositis (IBM).
    Gause A; Inderrieden DC; Laas R; Arlt AC; Gross WL
    Immunobiology; 2000 Aug; 202(2):199-203. PubMed ID: 10993295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion body myositis (IBM).
    Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
    Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N; Engel AG
    Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inclusion body myositis. Report of 4 cases].
    Basquiera AL; Caeiro F; Palacio S; Theaux R; Casale A; Lucero C; Alvarellos A
    Medicina (B Aires); 2002; 62(1):37-40. PubMed ID: 11965848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
    Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroconvulsive treatment for a patient with psychotic depression and inclusion body myositis.
    Ntatsaki E; D'Mello O; Lewis J; Underwood BR; Smith M; Head L
    J ECT; 2009 Jun; 25(2):125-8. PubMed ID: 18708945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion body myositis associated with hepatitis C virus infection.
    Tsuruta Y; Yamada T; Yoshimura T; Satake M; Ogata K; Yamamoto T; Furuya H; Kira J
    Fukuoka Igaku Zasshi; 2001 Nov; 92(11):370-6. PubMed ID: 11774706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis.
    Johnson LG; Collier KE; Edwards DJ; Philippe DL; Eastwood PR; Walters SE; Thickbroom GW; Mastaglia FL
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):178-84. PubMed ID: 19494728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatomyositis with inclusion body myositis pathology.
    Layzer R; Lee HS; Iverson D; Margeta M
    Muscle Nerve; 2009 Sep; 40(3):469-71. PubMed ID: 19623629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin.
    Amemiya K; Semino-Mora C; Granger RP; Dalakas MC
    Clin Immunol; 2000 Feb; 94(2):99-104. PubMed ID: 10637094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of inclusion body myositis.
    Li J; Yin C; Okamoto H; Jaffe H; Oldfield EH; Zhuang Z; Vortmeyer AO; Rushing EJ
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):826-33. PubMed ID: 16896316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and therapy of inclusion body myositis.
    Greenberg SA
    Curr Opin Neurol; 2012 Oct; 25(5):630-9. PubMed ID: 22941263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electromyographs of the flexor digitorum profundus muscle are useful for the diagnosis of inclusion body myositis.
    Hokkoku K; Sonoo M; Higashihara M; Stålberg E; Shimizu T
    Muscle Nerve; 2012 Aug; 46(2):181-6. PubMed ID: 22806366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and prognostic factors in sporadic inclusion body myositis.
    Lindberg C; Oldfors A
    Acta Neurol Scand; 2012 May; 125(5):353-8. PubMed ID: 21916852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.